Audrey Wei Lin Chia

Dr. Audrey Wei Lin Chia


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Asia-Pacific Journal of Ophthalmology
Verified
Journal Article
Open access
ACAudrey Wei Lin Chia
Audrey Wei Lin Chia
CNCheryl Mbbs Ngo
Cheryl Mbbs Ngo
NCNozhat Choudry
Nozhat Choudry
YYYutaka Msc Yamakawa
Yutaka Msc Yamakawa
DTDonald Mbbs Tan
Donald Mbbs Tan
Purpose: The purpose of this study was to assess the dose-response effects of low-dose atropine on myopia progression and safety in pediatric subjects with mild-to-moderate myopia. Methods: This phase II, randomized, double-masked, placebo-controlled study compared the efficacy and safety of atropine 0.0025%, 0.005%, and 0.01% with placebo in 99 children, aged 6–11 years, with mild-to-moderate myopia. Subjects received 1 drop in each eye at bedtime. The primary efficacy endpoint was change in spherical equivalent (SE), while secondary endpoints included changes in axial length (AL) and near logMAR (logarithm of the minimum angle of resolution) visual acuity and adverse effects. Results: The mean±SD changes in SE from baseline to 12 months in the placebo and atropine 0.0025%, 0.005%, and 0.01% groups were −0.55±0.471, −0.55±0.337, −0.33±0.473, and −0.39±0.519 D, respectively. The least squares mean differences (atropine−placebo) in the atropine 0.0025%, 0.005%, and 0.01% groups were 0.11 D (P=0.246), 0.23 D (P=0.009), and 0.25 D (P=0.006), respectively. Compared with placebo, the mean change in AL was significantly greater for atropine 0.005% (−0.09 mm, P=0.012) and 0.01% (−0.10 mm, P=0.003). There were no significant changes in near visual acuity in any of the treatment groups. The most common ocular adverse events were pruritus and blurred vision, each occurring in 4 (5.5%) atropine-treated children. Changes in mean pupil size and amplitude of accommodation were minimal. Conclusions: Atropine doses of 0.005% and 0.01% effectively reduced myopia progression in children but no effect was noted with 0.0025%. All doses of atropine were safe and well tolerated.

23 November 2024 in Asia-Pacific Journal of Ophthalmology
Verified
Journal Article
Open access
BSBryan Xiangrong Sim
Bryan Xiangrong Sim
RCRachel Chong
Rachel Chong
HHHla Myint Htoon
Hla Myint Htoon
MBMaithily Balakrishnan
Maithily Balakrishnan
NBNoel A. Brennan
Noel A. Brennan
ACAudrey Wei Lin Chia
Audrey Wei Lin Chia
This study aimed to investigate the longitudinal associations between myopic optic disc features and optical coherence tomography (OCT) measurements of peripapillary retinal nerve fibre layer (RNFL) thickness in young myopic children in Singapore. A prospective, single-site cohort study was conducted, involving children aged 7 to 16 years who participated in the PROM-Kids clinical cohort study from 2019 to 2022. Participants underwent annual assessments, including cycloplegic refraction, axial length measurements, fundus photography, and OCT imaging, with ocular magnification correction. Children were classified into low (LM, 0 to -3D), moderate (MM, -3.01 to -6D), and high (HM, > -6D) myopia, with or without treatment. Data from 1,000 children (right eye) were analyzed, including 521 with 2-year follow-up. At baseline, the mean age was 10.2 ± 1.6 years, with 46.4% male and 90.7% ethnic Chinese. HM children were older and exhibited greater optic disc tilt (ODT, 92% vs. 80%) and more peripapillary atrophy (PPA, 94% vs. 73%) compared to LM children. RNFL thickness decreased in the superior, inferior, and nasal quadrants but increased in the temporal quadrant with higher myopia. In the follow-up cohort, myopia progression was associated with thicker temporal quadrant and average RNFL, particularly in younger children. Prior treatment with myopia-control lenses was also associated with increased RNFL thickness in the superior quadrant. Optic disc changes occur early in life, even in low myopia. Increasing myopia is linked to varying RNFL thickness across quadrants and may be influenced by age and myopia treatment.

10 October 2019
Verified
Book Chapter
Open access
PDF file
ACAudrey Wei Lin Chia
Audrey Wei Lin Chia
STSu Ann Tay
Su Ann Tay
Our understanding of why myopia develops and how various interventions (such as life style modification, spectacles, contact lenses, and pharmacological agents) affect myopia progression has evolved over time. In this chapter, the theories behind the development of myopia (i.e., the effect of near versus outdoor activity, peripheral defocus, and genetic processes), and the various interventions available for the management of childhood myopia will be reviewed and discussed.

2 November 2025
Verified
Book Chapter
Open access
PDF file
LHLim Sing Hui
Lim Sing Hui
ACAudrey Wei Lin Chia
Audrey Wei Lin Chia
History of atopy (e.g. allergic rhinitis, eczema, drug/food allergies, etc.)

25 April 2026 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
MLMark Kit Lim
Mark Kit Lim
RCRachel Shujuan Chong
Rachel Shujuan Chong
MAMuna Al Ajmi
Muna Al Ajmi
HHHla Myint Htoon
Hla Myint Htoon
ACAudrey Wei Lin Chia
Audrey Wei Lin Chia

2 November 2025
Verified
Book Chapter
Open access
PDF file
LHLim Sing Hui
Lim Sing Hui
ACAudrey Wei Lin Chia
Audrey Wei Lin Chia
Parental or physician description of a white appearance (reflex) in the pupil.